CD117 expression in canine ovarian tumours

Mallon, HE; Ramírez, GA; Dolensek, T; Erles, K; Martí-Garcia, B; Priestnall, SL; Suárez-Bonnet, A

Abstract

Canine ovarian cancer poses a significant diagnostic and therapeutic challenge. The heterogeneous nature of ovarian tumours makes accurate histological identification difficult, whilst treatment is limited to surgical excision. The tyrosine kinase receptor CD117 is neo-expressed in many tumours and represents a potential diagnostic and prognostic biomarker and therapeutic target. This study aimed to establish if CD117 is neoexpressed in canine ovarian tumours. Immunohistochemistry was employed to assess expression of CD117 in 29 canine ovarian tumour samples. CD117 labelling was assessed with a semiquantitative immunoreactivity score, and the location of labelling was recorded as membranous, focal cytoplasmic or diffuse cytoplasmic. Histological morphology was assessed and used to assign subgroups based on growth pattern. Cytokeratin 7 labelling was used to indicate the tumour type as epithelial or sex-cord stromal in origin. Mitotic index, percentage of necrosis and vascular invasion were also assessed and evaluated for association with CD117 expression. Overall, 81% of ovarian tumours neoexpressed CD117 and normal ovarian tissue did not express CD117. Positive immunolabelling was seen in a subset of cells in both ovarian carcinomas (n = 20) and ovarian granulosa cell tumours (n = 3). There was no association between CD117 expression and patient age, histological subtype, mitotic index, percentage of necrosis or vascular invasion. This is the largest study to identify the expression of CD117 in canine ovarian tumours, but further research is needed to elucidate its prognostic and therapeutic value. (c) 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Citation

Mallon, H., Ramírez, G., Dolensek, T., Erles, K., Martí-Garcia, B., Priestnall, S., & Suárez-Bonnet, A. (2024). CD117 expression in canine ovarian tumours. Journal of Comparative Pathology, 212, 1-5. https://doi.org/10.1016/j.jcpa.2024.05.001

• Journal Article Type: Article
• Acceptance Date: May 16, 2024
• Online Publication Date: Jun 14, 2024
• Publication Date: 2024
• Deposit Date: Jul 19, 2024
• Publicly Available Date: Jul 19, 2024
• Journal: Journal of Comparative Pathology
• Print ISSN: 0021-9975
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 212
• Pages: 1-5
• DOI: https://doi.org/10.1016/j.jcpa.2024.05.001
• Keywords: canine; CD117; ovarian; tumour; C-KIT; CELL TUMORS; IMMUNOHISTOCHEMICAL CHARACTERIZATION; MUTATIONAL ANALYSIS; STEM-CELLS; BETA; PRODUCT; CANCER; PHENOTYPE; DIAGNOSIS